Ask AI
ProCE Banner Activity

Screening for DPYD Variants: Practical Guidance for Your Practice in my Candid Conversation With Dr Howard McLeod

Video

Testing for dihydropyrimidine dehydrogenase (DPD) deficiency can identify patients at risk for life-threatening toxicity from 5-FU and capecitabine. In this episode of Candid Conversations, Dr Howard McLeod explains how screening for DPYD variants can prevent severe toxicity and even death and offers practical guidance for integrating it into everyday oncology practice.

Released: December 15, 2025